Page 124 - Second Circuit News Today

The Second Circuit, for the first time, has addressed the scope of the Supreme Court's decision in FTC v. Actavis regarding the use of allegedly anticompetitive reverse payments by a brand drug manufacturer to settle patent infringement litigation ...

In CVS Pharmacy v. Forest Labs, 2nd Circuit affirms dismissal for reverse payments in alleged violation of antitrust laws to delay entry of generic version of drug p

The US Supreme Court on April 22, 2024 denied a petition for a writ of certiorari in the closely watched antitrust case United States Soccer Federation Inc. v. Relevent Sports LLC. The...

In Nwosuocha v. Glover, US Second Circuit Court of Appeals affirmed dismissal of copyright infringement claim by rap artist for failure to register the work in quest

Recent climate case decisions impact federal jurisdiction, local vs. state regulations, and international obligations, signaling heightened scrutiny and regulatory s

In Soliman v. Subway Franchisee Advertising Fund Trust, Second Circuit affirms dismissal of case for alleged violations of the federal Telephone Consumer Protection

A group of people whose life works have helped shape excellence in South Dakota and our nation are officially being inducted into the South Dakota Hall of Fame in 2024.

Alabama Attorney General Steve Marshall recently filed a 20 state amicus brief in an effort to shield Amish communities in rural New York from state sponsored backlash for exercising their religious freedoms.

Seyfarth Synopsis: One issue that has consistently divided the federal courts is whether an equal pay plaintiff can establish a prima faciecase of wage discrimination by pointing to a...

Celgene and parent Bristol-Myers Squibb pointed a New Jersey federal judge to the dismissal, recently upheld by the Second Circuit, of an antitrust suit over delayed generic competition to AbbVie's hypertension treatment Bystolic to argue the same logic applies to their bid to duck antitrust claims over cancer therapies.